Bacterial and fungal co-infection is a major barrier in COVID-19 patients: A specific management and therapeutic strategy is required.

Sahu, Tarun; Verma, Henu Kumar; Bhaskar, Lakkakula V K S

Sahu, Tarun; Verma, Henu Kumar; Bhaskar, Lakkakula V K S.

Afiliação

Sahu T; Department of Physiology, All India Institute of Medical Science, Raipur 492001, Chhattisgarh, India.
Verma HK; Department of Immunopathology, Institute of Lung Health and Immunity, Comprehensive Pneumology Center, Helmholtz Zentrum, Munich 85764, Germany. henu.verma@yahoo.com.
Bhaskar LVKS; Department of Zoology, Guru Ghasidas Vishwavidyalaya, Bilaspur 495001, Chhattisgarh, India.

World J Virol ; 11(2): 107-110, 2022 Mar 25.

Article em En | MEDLINE | ID: mdl-35433338

Palavras-chave

Bacterial co-infection; COVID-19; Co-infection; Fungal co-infection

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: World J Virol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Índia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: World J Virol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Índia